Crescent Capital BDC, Inc. CCAP FINANCIAL
Company Overview
Crescent Capital BDC, Inc. is as a business development company is a private debt fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Why Investors Should Care
Operating margin of 78.4% supports profitability.
Offers a dividend yield of 14.77%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -15.5%, earnings -53.1%.
- 5-Year Trend Long-term compounding — profit CAGR -8.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -15.50% |
Compounded Profit Growth
| 5 Years: | -8.79% |
| 1 Year: | -53.14% |
Stock Price Performance
| 1 Year: | -20.64% |
| 6 Months: | -14.19% |
| 3 Months: | -3.87% |
| 1 Month: | -12.32% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)35.16 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Attractive dividend yield of 14.77%.
- Generates positive free cash flow.
CONS
- Earnings shrank at -8.8% CAGR over 5 years.
- Trading 26.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CCAP Crescent Capital BDC, Inc. FINANCIAL | 10.29 | -114.33 | $379.14M | 14.77% | - | -0.46% | - | -8.79% |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -12.58M | -14.09M | -10.98M | -13.38M | -21.59M | -25.83M | -26.08M | -26.68M | -26.82M | -27.44M | -25.01M | -25.70M | -24.14M | -21.87M | -22.72M |
| Net Income | 16.68M | 16.21M | -890.00K | -2.38M | 7.78M | 22.58M | 22.62M | 28.00M | 20.39M | 15.27M | 3.90M | 15.01M | 7.10M | -15.51M | -3.25M |
| Diluted EPS | 0.45 | 0.39 | 0.50 | 0.52 | 0.54 | 0.56 | 0.59 | 0.63 | 0.59 | 0.64 | 0.45 | 0.46 | 0.46 | 0.42 | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Income | -26.69M | -44.11M | -56.83M | -100.29M | -106.78M | -98.69M |
| Net Income | 54.67M | 83.63M | 15.54M | 83.84M | 73.65M | 34.51M |
| Diluted EPS | 1.80 | 1.67 | 1.93 | 2.30 | 2.40 | 1.81 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.32B | 1.30B | 1.63B | 1.66B | 1.62B |
| Current Assets | - | - | - | - | - | - | - |
| Cash & Equivalents | - | 1.75M | 10.07M | 6.40M | 7.78M | 10.13M | 5.04M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | 9.95M | 14.25M | 12.17M | 17.35M |
| Total Liabilities | - | - | 665.52M | 690.34M | 884.78M | 915.64M | 916.10M |
| Current Liabilities | - | - | - | - | - | - | - |
| Long Term Debt | - | - | 631.04M | - | - | - | - |
| Total Debt | - | - | - | 654.46M | 844.78M | 875.84M | 873.76M |
| Total Equity | 406.92M | 560.00M | 652.28M | 612.54M | 742.59M | 740.64M | 706.04M |
| Shares Outstanding | - | - | - | 30.89M | 37.06M | 37.06M | 36.97M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -61.80M | -157.65M | 27.95M | 92.30M | 58.91M | 74.72M |
| Financing Cash Flow | 63.22M | 166.32M | -34.41M | -84.99M | -43.47M | -82.54M |
| Share Buybacks | 2.21M | - | - | - | - | 1.33M |
| Dividends Paid | 42.63M | 47.73M | 55.29M | 64.55M | 75.23M | 67.81M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | 9.8% | 12.8% | 2.5% | 11.3% | 9.9% | 4.9% |
| ROCE % | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Texas County & District Retirement System | 13.57% | 5.00M | $48.92M |
| 2 | Fidelity National Financial, Inc. | 11.41% | 4.21M | $41.13M |
| 3 | Blackstone Inc | 11.41% | 4.21M | $41.13M |
| 4 | Sun Life Financial Inc. | 6.04% | 2.23M | $21.77M |
| 5 | Ares Management LLC | 2.95% | 1.09M | $10.64M |
| 6 | Invesco Ltd. | 2.71% | 1.00M | $9.78M |
| 7 | RiverNorth Capital Management, LLC | 1.91% | 702.80K | $6.87M |
| 8 | North Ground Capital | 1.41% | 520.80K | $5.09M |
| 9 | UBS Group AG | 1.36% | 501.74K | $4.91M |
| 10 | Mariner, LLC | 1.20% | 441.12K | $4.31M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CCAP
Two-day Crescent Capital (CCAP) stock sale by 10% holder was pre-planned - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPeHp6YndUZGVaZHQxNTdGTWpGNEM4dzF5MTAyckJrMlBPNXNzOUdNMllfaTZwZjNTYVNPOXkxZEpxejRGeFZGc1NXVFFCaGhwVFBkWmViT19IaG5ONF9qa1hMam9qdHlCbzRBV1ZkamQ4NzFuTWxVcHlza0tRRUZxNnlDZnpFdVNJRW9yOD…
Crescent Capital BDC (NASDAQ:CCAP) Major Shareholder Sells $108,793.69 in Stock - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQR0R3NDVvZ1dBOHdFX1VNSXVRWGV0Yk5FVS1FR3hjeVhNTlk5SF84cmxteDFYM0VHV1E5RmpsLWJaU2Q2TzUxdFVxaEtxa3E2SkpRSk5HQlZSVm5lQW1jWk05VzNaRzVIXzhwSTFoZl9fQUVaVFBTd0RHMmt5N3B5WFdzUlRmVlRxV0lwSW…
Crescent Capital BDC (NASDAQ:CCAP) Major Shareholder Sells $51,813.74 in Stock - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOTG5qQ1pSODducTNJZzFVYnpQTjZsaEJYS0hXSVhKd2M4LW54MnYyd1ZWb3phY0NSQlk2VlFyTFpoV2lONlFEdDFzdUllNndZd0w2eDR1ai1KLV9uMGJMa01yQzNXbzNpNHRTTWVfYkNGTy16NjVKdFp5TjlvNDZLb2x2alZZVGIxSk1MaG…
Fidelity & Guaranty Life sells $160,566 of Crescent Capital BDC stock - Investing.com UK
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNc3VQampDb0RBN2ZDcmpmamVQT2Vqc1hFS2xKQVdqOVpSRFcyMFJfYkJGQlJqR04xQ29QeDF0NDZlM3BDNTZ3bVoxUWpnOWJlSlVjd19JMmNZaTMtWDkwbElxRlhzd0JVYW1fUVFDODlEcUxMazhTNW01emlLUFFRVWZqVUk0WDVvU01CNU…
Insider Sale: 10% owner at $CCAP Sells 27,195 Shares - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPSnd5VTViakRFZHhMb2NhMjdIQlk3NnBSd3JmUmc4RkMwSDJzUmVBb293alR6OHZFTWlrc1JWakwyU1ZkanRnMVhFTmh1RGpYLV9nNHNvNi1NYi1oajJjdldEbFlxM3ZTT1pSYlJUY1FrSVVFQmVubXlhNnlVZWNyejZMYzJpV1FhSG4zV0…
Crescent Capital BDC (CCAP) Misses Q2 Earnings and Revenue Estimates - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOR3BYS1p3NHVjLWNKbXNUTTZSZHJjTFduN013VnFwUUxEdzFLa0ZqTHVuMUZQTjZFdFpVa0ZqVTk3UmV2aEx2Y04tZjhNanBVbGVXZmltMGJlcmNCN0pNc0xTaWZmV21aSTJZVkpLdFNydzg1dVdoY1BINTJ6bjJGOFJiYTdMTTRCd1FHek…
CCAP — Frequently Asked Questions
What is the current share price of Crescent Capital BDC, Inc. (CCAP)?
As of 2026-09-19 21:16 PDT, Crescent Capital BDC, Inc. (CCAP) trades at $10.29 on NasdaqGM. Its 52-week range is $10.29 to $14.02.
What is the market capitalisation of CCAP?
Crescent Capital BDC, Inc. (CCAP) has a market capitalisation of $379.14M on NasdaqGM.
What is the P/E ratio of CCAP?
CCAP trades at a trailing price-to-earnings (P/E) ratio of -114.33. The industry average P/E is 12.89. Its price-to-book (P/B) ratio is 0.57.
Does CCAP pay a dividend?
Crescent Capital BDC, Inc. (CCAP) currently offers a dividend yield of 14.77%.
What is the return on equity (ROE) of CCAP?
CCAP has a return on equity (ROE) of -0.46%.
Is CCAP a good stock to buy?
This page provides a data-driven analysis of Crescent Capital BDC, Inc. (CCAP), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.